Outcomes of Patients with Newly Diagnosed Transplant-Ineligible Multiple Myeloma According to Clinical Trials Enrollment: Experience of a Single Institution

SIMPLE SUMMARY: Clinical trials (CTs) may not always reflect real-world medical practice, particularly in non-transplant-eligible (NTE) newly diagnosed multiple myeloma (NDMM) patients due to stringent recruitment criteria. Our objective was to assess exclusion rates, reasons, and survival outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Lobato, Luis Gerardo, Tovar, Natalia, de Daniel, Anna, Fernández de Larrea, Carlos, Cibeira, M. Teresa, Jiménez-Segura, Raquel, Moreno, David F., Oliver-Caldés, Aina, Bladé, Joan, Rosiñol, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649258/
https://www.ncbi.nlm.nih.gov/pubmed/37958434
http://dx.doi.org/10.3390/cancers15215261

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649258/
https://www.ncbi.nlm.nih.gov/pubmed/37958434
http://dx.doi.org/10.3390/cancers15215261

Ejemplares similares